Cambridge Heart, Inc. (CAMH) Release: Wellpoint To Cover Microvolt T-Wave Alternans Testing  
11/13/2006 11:22:01 AM

BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH) today announced that WellPoint/Anthem has revised its Coverage Policy Bulletin (MED.00041) on Microvolt T Wave Alternans agreeing to make it a covered benefit for its beneficiaries in California and 13 other states. The revised policy now states: